Market Tracker

09/29 5:16pm ET

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

7.30
Delayed Data
As of 3:59pm ET
 +0.26 / +3.69%
Today’s Change
3.07
Today|||52-Week Range
8.22
+18.70%
Year-to-Date
3 Top Stocks Under $10
1:55pm / MotleyFool.com - Paid Partner Content
Why Arrowhead Pharmaceuticals Stock Spiked Today
11:04am / MotleyFool.com - Paid Partner Content
Arrowhead Pharmaceuticals (ARWR) Stock Surges on Amgen Cardiovascular Drug Partnershi...
11:52am / TheStreet.com - Paid Partner Content
3 Ways Ionis Pharmaceuticals, Inc. Is Beating the Competition
Sep 19 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close7.04
Today’s open8.05
Day’s range7.20 - 8.09
Volume6,609,227
Average volume (3 months)684,978
Market cap$427.7M
Dividend yield--
Data as of 3:59pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-28.00%
Earnings growth (this year)+18.44%
Earnings growth (next 5 years)--
Revenue growth (last year)+118.29%
P/E ratioNM
Price/Sales864.88
Price/Book3.80

Competitors

 Today’s
change
Today’s
% change
RGNXRegenxbio Inc-0.49-3.41%
BSTCBiospecifics Technol...-2.04-4.35%
CASCCascadian Therapeuti...-0.12-7.19%
NVIVInVivo Therapeutics ...-0.33-4.76%
Data as of 3:59pm ET, 09/29/2016

Financials

Next reporting dateNovember 22, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$382.0K
Annual profit (last year)-$91.9M
Net profit margin-24,068.29%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christopher Richard Anzalone
Chief Operating Officer
Bruce D. Given
Corporate headquarters
Pasadena, California

Forecasts